39444 Federal Register / Vol. 82, No. 159 / Friday, August 18, 2017 / Notices 

• Ease of manufacture 

• Efficient norovirus detection 

Development Stage 

• In vivo data available (animal) 

Inventors: Kim Green, Ph.D. (NIAID); 

Gabriel Parra, Ph.D. (NIAID); Stanislav 

Sosnovtsev, Ph.D. (NIAID); Karin Bok, 

Ph.D. (NIAID); Carlos Sandoval-Jaime, 

Ph.D. (NIAID); Eugenio Abente, Ph.D. 

(NIAID) 

Intellectual Property: HHS Reference 

No. E–101–2013/0. 

Licensing Contact: Peter Soukas, J.D., 

(301) 594–8730; peter.soukas@nih.gov. 

Collaborative Research Opportunity: 

The National Institute of Allergy and 

Infectious Diseases is seeking statements 

of capability or interest from parties 

interested in collaborative research to 

further develop, evaluate or 

commercialize norovirus diagnostics or 

vaccines. For collaboration 

opportunities, please contact Peter 

Soukas, J.D., (301) 594–8730; 

peter.soukas@nih.gov. 

Dated: August 3, 2017. 

Suzanne Frisbie, 

Deputy Director, Technology Transfer and 

Intellectual Property Office, National Institute 

of Allergy and Infectious Diseases. 

[FR Doc. 2017–17438 Filed 8–17–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Advancing 

Translational Sciences; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Center for 

Advancing Translational Sciences Special 

Emphasis Panel Contract Review. 

Date: September 12, 2017. 

Time: 1:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, One 

Democracy Plaza, Room 1037, 6701 

Democracy Boulevard, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Rahat (Rani) Khan, Ph.D., 

Scientific Review Officer, Office of Scientific 

Review, National Center for Advancing, 

Translational Sciences, 6701 Democracy 

Blvd., Rm 1078, Bethesda, MD 20892, 301– 

894–7319, khanr2@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.859, Pharmacology, 

Physiology, and Biological Chemistry 

Research; 93.350, B—Cooperative 

Agreements; 93.859, Biomedical Research 

and Research Training, National Institutes of 

Health, HHS) 

Dated: August 14, 2017. 

David Clary, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–17427 Filed 8–17–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Biomedical 

Imaging and Bioengineering; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Biomedical Imaging and Bioengineering 

Special Emphasis Panel; NIBIB Team-Based 

R25 Review (2018/01). 

Date: September 28, 2017. 

Time: 09:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Two 

Democracy Plaza, Suite 920, 6707 Democracy 

Boulevard, Bethesda, MD 20892, (Virtual 

Meeting). 

Contact Person: Ruixia Zhou, Ph.D., 

Scientific Review Officer, 6707 Democracy 

Boulevard, Democracy Two Building, Suite 

957, Bethesda, MD 20892, (301) 496–4773, 

zhour@mail.nih.gov. 

Name of Committee: National Institute of 

Biomedical Imaging and Bioengineering 

Special Emphasis Panel; T32–R25 Review 

Meeting (2018/01). 

Date: October 24, 2017. 

Time: 09:30 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Two 

Democracy Plaza, Suite 920, 6707 Democracy 

Boulevard, Bethesda, MD 20892, (Virtual 

Meeting). 

Contact Person: John K. Hayes, Ph.D., 

Scientific Review Officer, 6707 Democracy 

Blvd., Suite 959, Democracy Two, Bethesda, 

MD 20892, (301) 451–3398, hayesj@

mail.nih.gov. 

Dated: August 14, 2017. 

David Clary, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–17429 Filed 8–17–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

U.S. Citizenship and Immigration 

Services 

[OMB Control Number 1615–0120] 

Agency Information Collection 

Activities; Extension, Without Change, 

of a Currently Approved Collection; 

Free Training for Civics and 

Citizenship of Adults, Form G–1190; 

Civics and Citizenship Toolkit, Form 

G–1515 

AGENCY: U.S. Citizenship and 

Immigration Services, Department of 

Homeland Security. 

ACTION: 30-Day notice. 

SUMMARY: The Department of Homeland 

Security (DHS), U.S. Citizenship and 

Immigration Services (USCIS) will be 

submitting the following information 

collection request to the Office of 

Management and Budget (OMB) for 

review and clearance in accordance 

with the Paperwork Reduction Act of 

1995. The purpose of this notice is to 

allow an additional 30 days for public 

comments. 

DATES: The purpose of this notice is to 

allow an additional 30 days for public 

comments. Comments are encouraged 

and will be accepted until September 

18, 2017. This process is conducted in 

accordance with 5 CFR 1320.10. 

ADDRESSES: Written comments and/or 

suggestions regarding the item(s) 

contained in this notice, especially 

regarding the estimated public burden 

and associated response time, must be 

directed to the OMB USCIS Desk Officer 

via email at dhsdeskofficer@

omb.eop.gov. All submissions received 

must include the agency name and the 

OMB Control Number 1615–0120 in the 

subject line. 

You may wish to consider limiting the 

amount of personal information that you 

mstockstill on DSK30JT082PROD with NOTICES